Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

202
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
202
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

220
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
220
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

208
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
208

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dopamine receptors in ocular surface biology: Current evidence and future directions.

Indian journal of ophthalmology·2026
Same author

Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy.

Indian journal of ophthalmology·2026
Same author

Long-term Outcomes of the Management of Chronic Refractory Ocular Allergy Using Allergen Immunotherapy.

Cornea·2026
Same author

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Investigative ophthalmology & visual science·2026
Same author

Biological cleansing: Toward improving ocular surface surgical outcomes.

Indian journal of ophthalmology·2026
Same author

Sesamol reprograms mitochondrial dysfunction and metabolic signaling to rescue endothelial degeneration in Fuchs' endothelial corneal dystrophy.

Free radical biology & medicine·2026
Same journal

Evaluation of the Toxicity and Efficacy of an Adeno-Associated Viral Vector Expressing <i>BEST1</i> Delivered by Subretinal Injection in a Canine Model of Human Bestrophinopathy.

Human gene therapy·2026
Same journal

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same journal

Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational Perspectives.

Human gene therapy·2026
Same journal

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration.

Human gene therapy·2026
Same journal

Hyperthermia-Enhanced Adeno-Associated Virus Gene Therapy: Mechanisms, Delivery Technologies, and Translational Potential.

Human gene therapy·2026
Same journal

Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory Meetings.

Human gene therapy·2026
查看所有相关文章

相关实验视频

Updated: Jan 10, 2026

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

9.2K

基于固定床生物反应器的AAV生产的多变量过程优化提高了总批次产量.

Ruchita Selot1, Ashish Khaparde1, Sharath Babu G R1

  • 1GROW Research Laboratory, Narayana Netralaya Foundation, Bengaluru, India.

Human gene therapy
|November 24, 2025
PubMed
概括
此摘要是机器生成的。

优化固定床生物反应器参数显著提高了腺相关病毒载体 (AAV) 生产. 这项研究实现了病毒产量的7.6倍增加,为可扩展的基因疗法制造铺平了道路.

关键词:
腺相关病毒 (AAV)固定床生物反应器 固定床生物反应器基因组标题的基因组标题.发展过程发展过程.过渡性转变的过渡性转变.三重等离子体系统的三重等离子体系统

更多相关视频

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K
Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

10.2K

相关实验视频

Last Updated: Jan 10, 2026

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

9.2K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K
Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

10.2K

科学领域:

  • 生物技术是生物技术.
  • 基因治疗 基因治疗
  • 生物加工是一种生物加工.

背景情况:

  • 基因相关病毒载体 (AAV) 对基因疗法至关重要,但面临着生产可扩展性的挑战.
  • 高质量,高产量的AAV生产对于临床应用至关重要.

研究的目的:

  • 在固定床生物反应器中优化腺相关病毒载体 (AAV) 生产.
  • 为了提高AAV产量和基因治疗应用的可扩展性.

主要方法:

  • 在固定床生物反应器中系统优化细胞播种密度,转染密度和DNA与细胞的比率.
  • 在附着的HEK-293T细胞,包装记者和治疗基因中利用过渡转染成AAV9囊体.
  • 在10天的生产周期中监测了生物反应器的关键参数 (pH,溶氧,葡萄糖).

主要成果:

  • 在固定床生物反应器中,达到高达3 × 10^9细胞/m2的细胞密度.
  • 与原型批量相比,病毒产量增加了大约7.6倍.
  • 获得了2.3 × 10^14 vg的平均AAV矢量产量,每个细胞的平均产量为1.4 × 10^5 vg/细胞.

结论:

  • 固定床生物反应器中优化过程参数是可扩展的AAV生产的可行策略.
  • 这种方法为为临床试验的AAV载体的成本效益制造提供了一个有前途的途径.
  • 优化的过程支持高细胞密度,并显著提高病毒产量.